These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 27629951

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study].
    He HQ, Li Q, Yan R, Zhou Y, Tang XW, Deng X, Xie SY, Chen ZP.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr 06; 51(4):336-340. PubMed ID: 28395468
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Susceptibility of medical students to vaccine-preventable viral diseases: a serological study.
    Kukino J, Naito T, Mitsuhashi K, Oshima H, Sekiya S, Isonuma H, Watanabe K, Dambara T, Hayashida Y.
    J Infect Chemother; 2004 Dec 06; 10(6):335-7. PubMed ID: 15614457
    [Abstract] [Full Text] [Related]

  • 7. Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children.
    Rafiei Tabatabaei S, Esteghamati AR, Shiva F, Fallah F, Radmanesh R, Abdinia B, Shamshiri AR, Khairkhah M, Shekari Ebrahimabad H, Karimi A.
    Arch Iran Med; 2013 Jan 06; 16(1):38-41. PubMed ID: 23273235
    [Abstract] [Full Text] [Related]

  • 8. Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.
    Kontio M, Palmu AA, Syrjänen RK, Lahdenkari M, Ruokokoski E, Davidkin I, Vaarala O, Melin M.
    J Infect Dis; 2016 Jun 15; 213(12):2005-13. PubMed ID: 26908733
    [Abstract] [Full Text] [Related]

  • 9. Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine.
    Seagle EE, Bednarczyk RA, Hill T, Fiebelkorn AP, Hickman CJ, Icenogle JP, Belongia EA, McLean HQ.
    Vaccine; 2018 Feb 01; 36(6):818-826. PubMed ID: 29317117
    [Abstract] [Full Text] [Related]

  • 10. Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants.
    D'Angio CT, Boohene PA, Mowrer A, Audet S, Menegus MA, Schmid DS, Beeler JA.
    Pediatrics; 2007 Mar 01; 119(3):e574-9. PubMed ID: 17332177
    [Abstract] [Full Text] [Related]

  • 11. Poor recall of prior exposure to varicella zoster, rubella, measles, or mumps in patients with IBD.
    Naganuma M, Nagahori M, Fujii T, Morio J, Saito E, Watanabe M.
    Inflamm Bowel Dis; 2013 Feb 01; 19(2):418-22. PubMed ID: 22605673
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of measles, rubella, mumps, and varicella antibodies among healthcare workers in Japan.
    Hatakeyama S, Moriya K, Itoyama S, Nukui Y, Uchida M, Shintani Y, Morisawa Y, Kimura S.
    Infect Control Hosp Epidemiol; 2004 Jul 01; 25(7):591-4. PubMed ID: 15301032
    [Abstract] [Full Text] [Related]

  • 13. Measles-mumps-rubella revaccination; 18 months vs. 4-6 years of age: potential impacts of schedule changes.
    Saffar MJ, Fathpour GR, Parsaei MR, Ajami A, Khalilian AR, Shojaei J, Saffar H.
    J Trop Pediatr; 2011 Oct 01; 57(5):347-51. PubMed ID: 21078605
    [Abstract] [Full Text] [Related]

  • 14. Measles Virus Neutralizing Antibody Response, Cell-Mediated Immunity, and Immunoglobulin G Antibody Avidity Before and After Receipt of a Third Dose of Measles, Mumps, and Rubella Vaccine in Young Adults.
    Fiebelkorn AP, Coleman LA, Belongia EA, Freeman SK, York D, Bi D, Kulkarni A, Audet S, Mercader S, McGrew M, Hickman CJ, Bellini WJ, Shivakoti R, Griffin DE, Beeler J.
    J Infect Dis; 2016 Apr 01; 213(7):1115-23. PubMed ID: 26597262
    [Abstract] [Full Text] [Related]

  • 15. Seroprevalence survey on measles, mumps, rubella and varicella antibodies in healthcare workers in Japan: sex, age, occupational-related differences and vaccine efficacy.
    Kumakura S, Shibata H, Onoda K, Nishimura N, Matsuda C, Hirose M.
    Epidemiol Infect; 2014 Jan 01; 142(1):12-9. PubMed ID: 23574767
    [Abstract] [Full Text] [Related]

  • 16. Determination of measles, mumps, and rubella immunization status using oral fluid samples.
    Thieme T, Piacentini S, Davidson S, Steingart K.
    JAMA; 1994 Jul 20; 272(3):219-21. PubMed ID: 8022041
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of anti-rubella, anti-measles and anti-mumps IgG antibodies in neonates and pregnant women in Catalonia (Spain) in 2013: susceptibility to measles increased from 2003 to 2013.
    Plans P, de Ory F, Campins M, Álvarez E, Payà T, Guisasola E, Compte C, Vellbé K, Sánchez C, Lozano MJ, Aran I, Bonmatí A, Carreras R, Jané M, Cabero L.
    Eur J Clin Microbiol Infect Dis; 2015 Jun 20; 34(6):1161-71. PubMed ID: 25666082
    [Abstract] [Full Text] [Related]

  • 18. Seroprevalence survey of varicella, measles, rubella, and hepatitis A and B viruses in a multinational healthcare workforce in Saudi Arabia.
    Almuneef MA, Memish ZA, Balkhy HH, Otaibi B, Helmi M.
    Infect Control Hosp Epidemiol; 2006 Nov 20; 27(11):1178-83. PubMed ID: 17080374
    [Abstract] [Full Text] [Related]

  • 19. Seroprevalence of measles and rubella antibodies in pregnant women Haiti, 2012.
    Fitter DL, Anselme R, Paluku G, Rey G, Flannery B, Tohme RA, Marston BJ, Griswold M, Boncy J, Vertefeuille JF.
    Vaccine; 2013 Dec 17; 32(1):69-73. PubMed ID: 24188751
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.